Peptan® Health

As the population ages, the drawbacks of aging are becoming more apparent. Osteoarthritis and osteopenia, two of the major health concerns, are among the leading causes of pain and disability.
It is now well known that collagen peptides can help to maintain bone and joint health to prevent osteopenia and osteoarthritis.

Collagen Peptides for Joint and Bone Health
The world health market is pushed by consumer concern over diseases and pulled by consumer fascination with well-being. The population is getting older, and growing old has its drawbacks: two of the major health concerns are osteoarthritis and osteoporosis, which are leading causes of disability. There is growing scientific evidence that Collagen Peptides can promote joint and bone health.

It is now well known that Collagen Peptides may help to maintain bone and joint health to prevent osteopenia (low bone mass) and osteoarthritis.

Osteopenia
According to the World Health Organiza¬tion (WHO), osteopenia is used to describe individuals who have a low bone mass and some increased risk of fracture. Their bone mass is not so low that they are deemed to have osteoporosis.

Osteoarthritis
Osteoarthritis is a joint affliction characterized by degenerative lesions of joint cartilage.
According to the World Health Organization, after the age of 50, 10% of men and 18% of women suffer from osteoarthritis.

Dynamic growth on the bone & joint health market
In 2009, Rousselot has received Frost & Sullivan Growth Strategy Excellence Award for its success within the European bone and joint health ingredients market.
Quality, strong market adequacy of Peptan®, as well as continuous efforts to enhance its recognition have been the basis of Rousselot success in this sector.